LGC acquires Rapid Genomics, bolstering its position in the application of NGS for high-throughput genotyping market in AgBio

News - Rapid Genomics is a leading company in genotyping applications via Next-Generation Sequencing

01 April 2022
LGC’s SARS-CoV-2 ultra-high throughput End-Point PCR test EUA authorised by FDA

News - Nexar™-based workflow enables simple, scalable, and cost-effective COVID-19 testing

27 April 2022
LGC’s new state-of-the-art site in Oxford will deliver critical diagnostics solutions and research

News - Facility will serve as home of The Native Antigen Company and an advanced workflow applications laboratory for LGC Biosearch Technologies

16 September 2022